Skip to main content
Loading

Clinical Development topic: Start with the End Goal in Mind: Efficiency in Creating Methods for Bioanalytical Endpoints in ADA, PK, and PD Assays

29 Oct 2024
Translational Immunology
Clinical Development topic: Start with the End Goal in Mind: Efficiency in Creating Methods for Bioanalytical Endpoints in ADA, PK, and PD Assays
  • Critical reagent risk mitigation strategies
  • Potential improvements in efficiency for preclinical and clinical bioanalytical testing
  • Bioanalytical method development and testing considerations for Cell and Gene therapies
Industry Experts
Matt Revitt, Managing Director, Strategic Services - Meso Scale
Wendy VanScyoc, Senior Manager, Field Application Support - Meso Scale